Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV

NCT00051090 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

HIV Infections
Hepatitis B

Interventions

DRUG: Telbivudine
DRUG: Lamivudine
DRUG: Efavirenz
DRUG: Didanosine
DRUG: Abacavir

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)